Form 4: Aethlon Medical Director Forfeits Shares for Tax Withholdings
Insider Transaction Report
Aethlon Medical Inc. Director Nicolas Gikakis forfeited 1,786 shares of common stock to cover tax withholdings related to the conversion of restricted stock units.
Summary
- Nicolas Gikakis, a Director of Aethlon Medical Inc. (AEMD), forfeited 1,786 shares of common stock on June 30, 2025.
- The forfeiture occurred at a market price of $1.2 per share.
- This transaction was executed to cover tax withholdings upon the conversion of an aggregate of 4,465 vested and outstanding restricted stock units into common stock.
- Following this transaction, Nicolas Gikakis beneficially owns 20,004 shares of Aethlon Medical Inc. common stock.
- The restricted stock units were part of a grant previously reported in a Form 4 filed on April 25, 2025.
Sentiment
Score: 5
Explanation: The transaction is a routine forfeiture of shares for tax purposes related to equity compensation, which is a neutral event for company operations or valuation.
Positives
- NA
Negatives
- NA
Risks
- NA
Future Outlook
NA
Management Comments
- NA
Industry Context
NA
Comparison to Industry Standards
- NA
Legal Proceedings
- NA
Related Party Transactions
- NA
Stakeholder Impact
- NA
Next Steps
- NA
Key Dates
| Date | Description |
|---|---|
| 04/25/2025 | Date of original Form 4 filing reporting the restricted stock unit grant. |
| 06/30/2025 | Date of the reported transaction (forfeiture of shares). |
| 07/01/2025 | Date the Form 4 was signed by the reporting person's attorney-in-fact. |
Keywords
AEMD, Aethlon Medical, Form 4, Insider Transaction, Stock Forfeiture, Tax Withholding, Restricted Stock Units, Equity Compensation, Nicolas Gikakis
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.